查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1755959

2032 年蛋白質工程市場預測：按產品、類型、技術、應用、最終用戶和地區進行的全球分析

Protein Engineering Market Forecasts to 2032 - Global Analysis By Product (Instruments, Consumables and Software & Services), Type, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球蛋白質工程市場預計在 2025 年達到 35 億美元，到 2032 年將達到 86 億美元，預測期內的複合年成長率為 16.2%。

蛋白質工程是指透過設計和改造蛋白質來增強或創造特定功能。科學家利用定向進化和理性設計等技術改變蛋白質的結構，以提高穩定性、活性和特異性。其應用包括開發用於工業生產的酵素、用於治療的抗體以及診斷蛋白。它結合分子生物學、計算建模和生物化學，以客製化蛋白質用於生物或工業用途。

擴大工業酵素的用途

生物技術和製藥業對高效能工業酵素的需求日益成長，推動了蛋白質工程市場的發展。這些酵素可以增強藥物製造和生質燃料生產等製程。對永續且經濟高效的工業解決方案的需求也推動了市場的成長。基因工程技術的進步使得高性能酵素的設計成為可能。日益成長的生物加工應用也支持了市場的擴張。在產業需求的推動下，蛋白質工程正在經歷顯著的成長。

研發成本高

蛋白質工程需要大量的研究投入，包括先進的計算工具和實驗設備。設計新型蛋白質的複雜性增加了開發成本。小型生物技術公司在進行創新計劃時往往面臨資金限制。蛋白質最佳化需要時間，這增加了成本。高昂的成本可能會延遲新解決方案的市場准入。經濟壁壘是一項挑戰，研發成本也阻礙了市場成長。

新型生技藥品的開發

單株抗體和基因治療藥物等新型生技藥品的開發為蛋白質工程提供了重大機會。這些生技藥品解決了癌症和罕見疾病等領域尚未滿足的醫療需求。蛋白質設計技術的進步提高了生技藥品的療效和特異性。個人化醫療投資的不斷增加推動了對重組蛋白的需求。突破性治療方法的潛力增強了市場樂觀情緒。在醫療創新的推動下，新型生技藥品有望顯著成長。

智慧財產糾紛

蛋白質工程技術的智慧財產權糾紛可能阻礙市場成長。生技公司之間的專利糾紛可能會延遲產品開發和商業化。蛋白質工程領域的專利格局複雜，導致法律不確定性。高昂的訴訟成本可能會使中小企業的管理資源緊張。專有技術糾紛擾亂市場穩定。受法律挑戰的影響，智慧財產權糾紛威脅著市場的永續發展。

COVID-19的影響：

新冠疫情加速了疫苗和療法研發領域對蛋白質工程的需求。然而，研究活動和供應鏈的中斷導致非新冠疫情計劃出現延誤。快速疫苗研發的重點凸顯了工程蛋白質的重要性。疫情期間，預算重新分配限制了其他蛋白質工程舉措的資金。疫情後的復甦刺激了對生技藥品和工業酵素的投資。在醫療保健重點的推動下，市場正在復甦，並重新聚焦。

預計設備部分將成為預測期內最大的部分

由於先進工具在蛋白質設計和分析中發揮著至關重要的作用，預計儀器儀表領域將在預測期內佔據最大的市場佔有率佔有率。高通量篩檢系統和運算平台正在推動對專用儀器儀表的需求。蛋白質工程計劃日益複雜，也推動了它們的應用。這些儀器儀表能夠實現工業和醫療應用中的精確蛋白質修飾。生物技術研發投入的不斷增加也進一步推動了市場的成長。由於技術進步，儀器儀表領域預計將佔據最大的市場佔有率。

預計預測期內單株抗體部分將以最高的複合年成長率成長。

在預測期內，單株抗體領域預計將實現最高成長率，這得益於其在癌症和自體免疫疾病標靶治療中的關鍵作用。蛋白質工程的進步提高了抗體的特異性和治療效果。慢性病的增加推動了對單株抗體的需求。對下一代生技藥品的持續研究將推動市場擴張。對個人化醫療的關注將加速其應用。在醫學突破的推動下，該領域將實現最高成長率。

佔比最大的地區：

在預測期內，由於生物技術和製藥行業的成長，預計亞太地區將佔據最大的市場佔有率。中國和印度等國家正大力投資生物加工和生技藥品開發。該地區對可負擔醫療保健解決方案的重視推動了對工程蛋白質的需求。政府對生物技術創新的支持將促進市場成長。快速的工業化將進一步鞏固市場地位。在強勁的生物技術成長的支持下，亞太地區正引領全球市場。

複合年成長率最高的地區：

在預測期內，由於先進的科研基礎設施和生物技術創新，北美預計將實現最高的複合年成長率。該地區對個人化醫療和新型生技藥品的關注正在推動需求成長。大型製藥企業對研發的巨額投資正在推動市場擴張。領先生物技術公司的存在正在推動市場成長。對創新治療方法的監管支持鞏固了該地區的地位。在尖端研究的推動下，北美市場將快速成長。

免費客製化服務

訂閱此報告的客戶可享有以下免費自訂選項之一：

  • 公司簡介
    • 全面分析其他市場參與者（最多 3 家公司）
    • 主要企業的SWOT分析（最多3家公司）
  • 地理細分
    • 根據客戶興趣對主要國家市場進行估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 研究範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 主要研究資料
    • 次級研究資訊來源
    • 先決條件

第3章市場走勢分析

  • 驅動程式
  • 限制因素
  • 機會
  • 威脅
  • 產品分析
  • 技術分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買家的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球蛋白質工程市場（按產品）

  • 裝置
  • 耗材
  • 軟體和服務

6. 全球蛋白質工程市場（按類型）

  • 單株抗體
  • 促紅血球生成素
  • 干擾素
  • 疫苗
  • 集落刺激因子
  • 生長激素
  • 凝血因子
  • 其他類型

7. 全球蛋白質工程市場（按技術）

  • 合理蛋白質設計
  • 不合理的蛋白質設計

8. 全球蛋白質工程市場（按應用）

  • 藥物研發
  • 治療應用
  • 工業酵素開發
  • 診斷
  • 其他用途

9. 全球蛋白質工程市場（依最終用戶）

  • 生物製藥公司
  • 受託研究機構
  • 學術研究所

第10章全球蛋白質工程市場（按地區）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第11章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章 公司概況

  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Merck KGaA
  • Bruker Corporation
  • Waters Corporation
  • PerkinElmer, Inc.
  • Amgen Inc.
  • Eli Lilly and Company
  • Genentech, Inc.
  • Codexis, Inc.
  • Genscript Biotech Corporation
  • Integrated DNA Technologies, Inc.
  • Novo Nordisk A/S
  • Sanofi SA
  • Johnson & Johnson
  • Vertex Pharmaceuticals Incorporated
  • Lonza Group
  • Kyowa Kirin Co., Ltd.
Product Code: SMRC29853

According to Stratistics MRC, the Global Protein Engineering Market is accounted for $3.5 billion in 2025 and is expected to reach $8.6 billion by 2032 growing at a CAGR of 16.2% during the forecast period. Protein engineering is the design and modification of proteins to enhance or create specific functions. Using techniques like directed evolution and rational design, scientists alter protein structures to improve stability, activity, or specificity. Applications include developing enzymes for industrial processes, antibodies for therapeutics, and proteins for diagnostics. It combines molecular biology, computational modeling, and biochemistry to tailor proteins for targeted biological or industrial purposes.

Market Dynamics:

Driver:

Increased use in industrial enzymes

The growing demand for efficient industrial enzymes in biotechnology and pharmaceuticals drives the protein engineering market. These enzymes enhance processes like drug manufacturing and biofuel production. The need for sustainable and cost-effective industrial solutions fuels market growth. Advances in genetic engineering techniques enable the design of high-performance enzymes. The rise in bioprocessing applications supports market expansion. Fueled by industrial needs, protein engineering is experiencing significant growth.

Restraint:

High R&D costs

Protein engineering requires substantial investment in research, including advanced computational tools and laboratory equipment. The complexity of designing novel proteins increases development costs. Small biotech firms often face financial constraints in pursuing innovative projects. The lengthy process of protein optimization adds to the expense. High costs can delay market entry for new solutions. Triggered by financial barriers, R&D costs challenge market growth.

Opportunity:

Development of novel biologics

The development of novel biologics, such as monoclonal antibodies and gene therapies, presents significant opportunities for protein engineering. These biologics address unmet medical needs in areas like cancer and rare diseases. Advances in protein design techniques enhance the efficacy and specificity of biologics. Growing investments in personalized medicine drive demand for engineered proteins. The potential for breakthrough therapies fuels market optimism. Spurred by medical innovations, novel biologics offer substantial growth prospects.

Threat:

Intellectual property disputes

Intellectual property disputes over protein engineering technologies can hinder market growth. Patent conflicts among biotech firms may delay product development and commercialization. The complexity of patent landscapes in protein engineering creates legal uncertainties. High litigation costs can strain resources for smaller companies. Disputes over proprietary techniques disrupt market stability. Influenced by legal challenges, IP disputes threaten sustained market progress.

Covid-19 Impact:

The COVID-19 pandemic accelerated demand for protein engineering in vaccine and therapeutic development. However, disruptions in research activities and supply chains delayed non-COVID projects. The focus on rapid vaccine development highlighted the importance of engineered proteins. Budget reallocations limited funding for other protein engineering initiatives during the crisis. The post-pandemic recovery has spurred investments in biologics and industrial enzymes. Guided by healthcare priorities, the market is rebounding with renewed focus.

The instruments segment is expected to be the largest during the forecast period

The instruments segment is expected to account for the largest market share during the forecast period, due to the critical role of advanced tools in protein design and analysis. High-throughput screening systems and computational platforms drive demand for specialized instruments. The growing complexity of protein engineering projects fuels their adoption. These instruments enable precise protein modification for industrial and medical applications. Rising investments in biotech R&D further support market growth. Powered by technological advancements, the instruments segment holds the largest market share.

The monoclonal antibodies segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the monoclonal antibodies segment is predicted to witness the highest growth rate, due to their critical role in targeted therapies for cancer and autoimmune diseases. Advances in protein engineering enhance their specificity and therapeutic efficacy. The rising prevalence of chronic diseases drives demand for monoclonal antibodies. Ongoing research into next-generation biologics fuels market expansion. The focus on personalized medicine accelerates its adoption. Propelled by medical breakthroughs, this segment is set for the highest growth rate.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to its growing biotechnology and pharmaceutical industries. Countries like China and India are investing heavily in bioprocessing and biologics development. The region's focus on affordable healthcare solutions drives demand for engineered proteins. Government support for biotech innovation bolsters market growth. Rapid industrialization further strengthens the market's position. Backed by robust biotech growth, Asia Pacific leads the global market.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, due to its advanced research infrastructure and biotech innovation. The region's focus on personalized medicine and novel biologics fuels demand. Significant investments in R&D by major pharmaceutical companies drive market expansion. The presence of leading biotech firms enhances market growth. Regulatory support for innovative therapies strengthens the region's position. Motivated by cutting-edge research, North America is poised for rapid market growth.

Key players in the market

Some of the key players in Protein Engineering Market include Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Merck KGaA, Bruker Corporation, Waters Corporation, PerkinElmer, Inc., Amgen Inc., Eli Lilly and Company, Genentech, Inc., Codexis, Inc., Genscript Biotech Corporation, Integrated DNA Technologies, Inc., Novo Nordisk A/S, Sanofi S.A., Johnson & Johnson, Vertex Pharmaceuticals Incorporated, Lonza Group, and Kyowa Kirin Co., Ltd.

Key Developments:

In March 2025, Merck KGaA opened a biologics innovation hub in Asia Pacific, focusing on protein engineering for novel therapeutics. The facility leverages AI and high-throughput screening to develop targeted biologics, addressing unmet medical needs.

In February 2025, Agilent Technologies launched a next-generation protein analysis system for biologics research. Equipped with advanced spectrometry, it supports precise protein modification for industrial and medical applications, enhancing research efficiency and scalability.

Products Covered:

  • Instruments
  • Consumables
  • Software & Services

Types Covered:

  • Monoclonal Antibodies
  • Erythropoietin
  • Interferons
  • Vaccines
  • Colony-stimulating Factors
  • Growth Hormones
  • Coagulation Factors
  • Other Types

Technologies Covered:

  • Rational Protein Design
  • Irrational Protein Design

Applications Covered:

  • Drug Discovery & Development
  • Therapeutic Applications
  • Industrial Enzyme Development
  • Diagnostics
  • Other Applications

End Users Covered:

  • Biopharmaceutical Companies
  • Contract Research Organizations
  • Academic Research Institutes

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Protein Engineering Market, By Product

  • 5.1 Introduction
  • 5.2 Instruments
  • 5.3 Consumables
  • 5.4 Software & Services

6 Global Protein Engineering Market, By Type

  • 6.1 Introduction
  • 6.2 Monoclonal Antibodies
  • 6.3 Erythropoietin
  • 6.4 Interferons
  • 6.5 Vaccines
  • 6.6 Colony-stimulating Factors
  • 6.7 Growth Hormones
  • 6.8 Coagulation Factors
  • 6.9 Other Types

7 Global Protein Engineering Market, By Technology

  • 7.1 Introduction
  • 7.2 Rational Protein Design
  • 7.3 Irrational Protein Design

8 Global Protein Engineering Market, By Application

  • 8.1 Introduction
  • 8.2 Drug Discovery & Development
  • 8.3 Therapeutic Applications
  • 8.4 Industrial Enzyme Development
  • 8.5 Diagnostics
  • 8.6 Other Applications

9 Global Protein Engineering Market, By End User

  • 9.1 Introduction
  • 9.2 Biopharmaceutical Companies
  • 9.3 Contract Research Organizations
  • 9.4 Academic Research Institutes

10 Global Protein Engineering Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Thermo Fisher Scientific Inc.
  • 12.2 Danaher Corporation
  • 12.3 Agilent Technologies, Inc.
  • 12.4 Bio-Rad Laboratories, Inc.
  • 12.5 Merck KGaA
  • 12.6 Bruker Corporation
  • 12.7 Waters Corporation
  • 12.8 PerkinElmer, Inc.
  • 12.9 Amgen Inc.
  • 12.10 Eli Lilly and Company
  • 12.11 Genentech, Inc.
  • 12.12 Codexis, Inc.
  • 12.13 Genscript Biotech Corporation
  • 12.14 Integrated DNA Technologies, Inc.
  • 12.15 Novo Nordisk A/S
  • 12.16 Sanofi S.A.
  • 12.17 Johnson & Johnson
  • 12.18 Vertex Pharmaceuticals Incorporated
  • 12.19 Lonza Group
  • 12.20 Kyowa Kirin Co., Ltd.

List of Tables

  • Table 1 Global Protein Engineering Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Protein Engineering Market Outlook, By Product (2024-2032) ($MN)
  • Table 3 Global Protein Engineering Market Outlook, By Instruments (2024-2032) ($MN)
  • Table 4 Global Protein Engineering Market Outlook, By Consumables (2024-2032) ($MN)
  • Table 5 Global Protein Engineering Market Outlook, By Software & Services (2024-2032) ($MN)
  • Table 6 Global Protein Engineering Market Outlook, By Type (2024-2032) ($MN)
  • Table 7 Global Protein Engineering Market Outlook, By Monoclonal Antibodies (2024-2032) ($MN)
  • Table 8 Global Protein Engineering Market Outlook, By Erythropoietin (2024-2032) ($MN)
  • Table 9 Global Protein Engineering Market Outlook, By Interferons (2024-2032) ($MN)
  • Table 10 Global Protein Engineering Market Outlook, By Vaccines (2024-2032) ($MN)
  • Table 11 Global Protein Engineering Market Outlook, By Colony-stimulating Factors (2024-2032) ($MN)
  • Table 12 Global Protein Engineering Market Outlook, By Growth Hormones (2024-2032) ($MN)
  • Table 13 Global Protein Engineering Market Outlook, By Coagulation Factors (2024-2032) ($MN)
  • Table 14 Global Protein Engineering Market Outlook, By Other Types (2024-2032) ($MN)
  • Table 15 Global Protein Engineering Market Outlook, By Technology (2024-2032) ($MN)
  • Table 16 Global Protein Engineering Market Outlook, By Rational Protein Design (2024-2032) ($MN)
  • Table 17 Global Protein Engineering Market Outlook, By Irrational Protein Design (2024-2032) ($MN)
  • Table 18 Global Protein Engineering Market Outlook, By Application (2024-2032) ($MN)
  • Table 19 Global Protein Engineering Market Outlook, By Drug Discovery & Development (2024-2032) ($MN)
  • Table 20 Global Protein Engineering Market Outlook, By Therapeutic Applications (2024-2032) ($MN)
  • Table 21 Global Protein Engineering Market Outlook, By Industrial Enzyme Development (2024-2032) ($MN)
  • Table 22 Global Protein Engineering Market Outlook, By Diagnostics (2024-2032) ($MN)
  • Table 23 Global Protein Engineering Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 24 Global Protein Engineering Market Outlook, By End User (2024-2032) ($MN)
  • Table 25 Global Protein Engineering Market Outlook, By Biopharmaceutical Companies (2024-2032) ($MN)
  • Table 26 Global Protein Engineering Market Outlook, By Contract Research Organizations (2024-2032) ($MN)
  • Table 27 Global Protein Engineering Market Outlook, By Academic Research Institutes (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.